These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16123717)

  • 41. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.
    Kayali Z; Tan S; Shinkunas L; Voigt M; LaBrecque DR; Stapleton JT; Brown KE; Schmidt WN
    J Viral Hepat; 2007 Jan; 14(1):11-21. PubMed ID: 17212639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
    Klintmalm GB; Davis GL; Teperman L; Netto GJ; Washburn K; Rudich SM; Pomfret EA; Vargas HE; Brown R; Eckhoff D; Pruett TL; Roberts J; Mulligan DC; Charlton MR; Heffron TG; Ham JM; Douglas DD; Sher L; Baliga PK; Kinkhabwala M; Koneru B; Abecassis M; Millis M; Jennings LW; Fasola CG
    Liver Transpl; 2011 Dec; 17(12):1394-403. PubMed ID: 21850690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum hepatitis C virus RNA levels and histologic findings in liver allografts with early recurrent hepatitis C.
    Park YN; Boros P; Zhang DY; Sheiner P; Kim-Schluger L; Thung SN
    Arch Pathol Lab Med; 2000 Nov; 124(11):1623-7. PubMed ID: 11079013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation.
    Massaguer A; Ramírez S; Carrión JA; González P; Sánchez-Tapias JM; Forns X
    Am J Transplant; 2007 Sep; 7(9):2172-9. PubMed ID: 17608833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A model to predict severe HCV-related disease following liver transplantation.
    Berenguer M; Crippin J; Gish R; Bass N; Bostrom A; Netto G; Alonzo J; Garcia-Kennedy R; Rayón JM; Wright TL
    Hepatology; 2003 Jul; 38(1):34-41. PubMed ID: 12829984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver Retransplantation for Recurrence of HCV-Related Cirrhosis Using Hepatitis C-Positive Allografts: A 19-Year OPTN Analysis.
    Torosian JC; Leiby BE; Fenkel JM; Frank AM; Ramirez CG; Doria C
    Ann Transplant; 2016 May; 21():262-9. PubMed ID: 27137953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes in pediatric hepatitis C transplant recipients: analysis of the UNOS database.
    Gupta M; Bahirwani R; Levine MH; Malik S; Goldberg D; Reddy KR; Shaked A
    Pediatr Transplant; 2015 Mar; 19(2):153-63. PubMed ID: 25495572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation.
    Horster S; Bäuerlein FJ; Mandel P; Raziorrouh B; Hopf C; Stemmler HJ; Guba M; Angele M; Stangl M; Rentsch M; Frey L; Kaspar M; Kaczmarek I; Eberle J; Nickel T; Gruener N; Zachoval R; Diepolder H
    Transpl Infect Dis; 2013 Jun; 15(3):306-13. PubMed ID: 23489913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients.
    Campos-Varela I; Castells L; Esteban JI; Bes M; Rodríguez-Frías F; Sapisochin G; Allende H; Charco R; Esteban R
    Transplantation; 2012 Feb; 93(4):450-3. PubMed ID: 22262129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
    Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
    Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
    J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
    Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.
    Denewar AA; Monem El-Hendy YA; Wafa EW; Ghorab AA; Sheashaa HA; Rashad RH; Nagib AM; Neamatallah AH; Abbas MH; Shokeir AA
    Exp Clin Transplant; 2015 Oct; 13(5):402-7. PubMed ID: 26450463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.